US Broker Ratings

Tenet Healthcare Corporation (THC) Stock Analysis: Evaluating a Strong 8.91% Potential Upside

With a market capitalization of $20.51 billion, Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player in the healthcare sector, specializing in medical care facilities across the United States...

Masimo Corporation (MASI) Stock Analysis: Stable Growth with a 24.99% Return on Equity

Investors considering opportunities in the healthcare sector should not overlook Masimo Corporation (NASDAQ: MASI), a key player in the medical devices industry. Known for its innovative patient monitoring technologies, Masimo..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 14.74% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) has been capturing the attention of biotech investors, and for good reason. The United Kingdom-based biopharmaceutical company focuses on the development and commercialization of innovative..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring the 7.52% Upside Potential and Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry, offering a comprehensive suite of laboratory services. Headquartered in Burlington, North..

Cigna Group (CI) Stock Analysis: Exploring a Potential 23% Upside in the Healthcare Sector

The Cigna Group (NYSE: CI), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking long-term growth and stability. With a market capitalization of $73.74..

Humana Inc. (HUM) Stock Analysis: Evaluating Healthcare Growth with a 12% Upside Potential

Humana Inc. (NYSE: HUM), a stalwart in the healthcare sector, is capturing investor attention with its robust market presence and the potential for a 12.08% upside, as indicated by recent..

Insulet Corporation (PODD) Stock Analysis: Eyeing a 42% Upside with Robust Revenue Growth

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector with its innovative insulin delivery systems that have captured the attention of investors and analysts alike. With a current market..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. With a robust market capitalization of..

BeOne Medicines Ltd. (ONC): Investor Outlook on a Biotechnology Powerhouse with a 31.53% Upside Potential

BeOne Medicines Ltd. (ONC), headquartered in Basel, Switzerland, is capturing investor attention with its robust pipeline of oncology treatments and an impressive potential upside of 31.53%. This biotechnology stalwart is..

GSK plc (GSK) Stock Analysis: Evaluating a 12.36% Potential Upside in the Healthcare Sector

GSK plc (GSK) stands as a formidable player in the healthcare sector, with its roots tracing back to 1715. Headquartered in London, this British multinational pharmaceutical company operates through two..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring Growth and Dividend Potential in the Healthcare Sector

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, continues to capture investor interest with its robust market presence and promising growth trajectory. With a market capitalization..

Henry Schein (HSIC) Stock Analysis: Healthcare Giant with a 4.15% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, is drawing investor attention with its strategic positioning in the medical distribution industry. With a market cap of..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 6.45% Potential Upside in the Healthcare Sector

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, is carving a niche in the diagnostics and research industry. Based in the Netherlands, Qiagen specializes in transforming biological samples..

Penumbra, Inc. (PEN) Stock Analysis: Evaluating a 12.58% Potential Upside in the Thriving Medical Devices Sector

Penumbra, Inc. (PEN), a prominent player in the healthcare sector, specializes in the innovation and distribution of cutting-edge medical devices. Based in Alameda, California, this company has carved a niche..

Solventum Corporation (SOLV) Stock Analysis: Insights into a Healthcare Innovator with Strong ROE

Solventum Corporation (SOLV), a key player in the healthcare sector, has captured investor attention with a market cap of $14.8 billion. Specializing in medical instruments and supplies, Solventum operates through..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Promising 5.69% Upside Amidst Healthcare Sector Dynamics

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, stands out with its expansive range of mission-critical products and services catering to diverse industries, including biopharma and healthcare...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Potential with a 17.2% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP), a notable player in the healthcare sector’s diagnostics and research industry, has captured investor attention with its impressive 17.2% revenue growth. The Cincinnati-based company offers..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 35% Potential Upside for Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading player in the healthcare sector, is renowned for its cutting-edge medical instruments and supplies. The company, headquartered in Sunnyvale, California, has carved out..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unlocking Growth in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has long been an influential player in the healthcare sector, particularly within the medical devices industry. With a robust market capitalization of $18.17 billion,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 16.77% Upside Potential Amidst Strong Buy Ratings

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust pipeline and a promising upside potential of 16.77%. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds